GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novan Inc (OTCPK:NOVNW) » Definitions » Buyback Yield %

Novan (NOVNW) Buyback Yield % : 0.00 (As of Dec. 14, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Novan Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Novan's current buyback yield was 0.00%.


Novan Buyback Yield % Historical Data

The historical data trend for Novan's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novan Buyback Yield % Chart

Novan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only - - - - -

Novan Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Novan's Buyback Yield %

For the Biotechnology subindustry, Novan's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novan's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novan's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Novan's Buyback Yield % falls into.



Novan Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Novan's Buyback Yield for the fiscal year that ended in Dec. 2022 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 15.917) /
=N/A%

Novan's annualized Buyback Yield for the quarter that ended in Mar. 2023 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 6.475) * 4 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Mar. 2023) data.


Novan Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Novan's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Novan Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 64, Pittsboro, NC, USA, 27312
NVN Liquidation Inc Formerly Novan Inc is a dermatology company focused on developing and commercializing therapeutic products for skin diseases. It is developing SB206 as a topical prescription gel for the treatment of viral skin infections. The company's product portfolio includes; Wynzora Cream for the treatment of plaque psoriasis, Rhofade cream for the treatment of persistent facial erythema, Minolira tablets to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients, Cloderm cream for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, Sitavig tablets for the treatment of recurrent herpes labialis in immunocompetent adults, and Nuvail nail solution for managing signs and symptoms of nail dystrophy.

Novan Headlines

From GuruFocus

Novan Inc To Host Analyst and Investor Event Transcript

By GuruFocus Research 02-14-2024

Novan Announces Closing of $6.0 Million Registered Direct Offering

By sperokesalga sperokesalga 03-17-2023

Q4 2021 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2022 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novan Inc SB206 Clinical Data Update Call Transcript

By GuruFocus Research 02-14-2024

Q2 2022 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novan to Report First Quarter 2023 Financial Results on May 15, 2023

By sperokesalga sperokesalga 05-08-2023

Q1 2023 Novan Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024